Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Scale-Up Processes01:14

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Response Surface Methodology01:16

Response Surface Methodology

Response Surface Methodology (RSM) is a collection of statistical and mathematical techniques used to develop, improve, and optimize processes. It is particularly valuable when many input variables or factors potentially influence a response variable.
The process of RSM involves several key steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next generation automated traceless cell chromatography platform for GMP-compliant cell isolation and activation.

Scientific reports·2022
Same author

A fully automated robotic system for high throughput fermentation.

Clinics in laboratory medicine·2007
Same author

Evaluation of the applicability of backscattered light measurements to the determination of microbial cell densities in microtiter plates.

Analytical and bioanalytical chemistry·2006
Same author

Oxygen limitation is a pitfall during screening for industrial strains.

Applied microbiology and biotechnology·2006
Same author

Oxygen transfer phenomena in 48-well microtiter plates: determination by optical monitoring of sulfite oxidation and verification by real-time measurement during microbial growth.

Biotechnology and bioengineering·2005
Same author

Monitoring aerobic Escherichia coli growth in shaken microplates by measurement of culture fluorescence.

BioTechniques·2004

Related Experiment Video

Updated: May 25, 2026

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins
05:57

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins

Published on: April 26, 2024

Proposal on How To Conduct a Biopharmaceutical Process Failure Mode and Effect Analysis (FMEA) as a Risk Assessment

Hartmut F Zimmermann1, Norbert Hentschel

  • 1Associate Director Process Validation, Boehringer Ingelheim.

PDA Journal of Pharmaceutical Science and Technology
|February 2, 2012
PubMed
Summary
This summary is machine-generated.

This guideline details conducting Failure Mode and Effect Analysis (FMEA) for biopharmaceutical processes. It provides a specialized rating table to identify and manage risks in drug manufacturing, enhancing medicine safety.

More Related Videos

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

Fluorescence Micropipette Aspiration Assay to Investigate Red Blood Cell Mechanosensing
07:02

Fluorescence Micropipette Aspiration Assay to Investigate Red Blood Cell Mechanosensing

Published on: January 12, 2024

Related Experiment Videos

Last Updated: May 25, 2026

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins
05:57

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins

Published on: April 26, 2024

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

Fluorescence Micropipette Aspiration Assay to Investigate Red Blood Cell Mechanosensing
07:02

Fluorescence Micropipette Aspiration Assay to Investigate Red Blood Cell Mechanosensing

Published on: January 12, 2024

Area of Science:

  • Pharmaceutical Manufacturing
  • Biotechnology
  • Quality Risk Management

Background:

  • International Conference on Harmonization (ICH) Q9 guideline mandates risk management in pharmaceutical product lifecycles.
  • Failure Mode and Effect Analysis (FMEA) is a standard risk assessment tool, but its adaptation to biopharmaceutical processes presents challenges.
  • Biopharmaceutical processes differ significantly from traditional mechanical and electrical industries, requiring tailored risk management approaches.

Purpose of the Study:

  • To provide a comprehensive guideline for conducting biopharmaceutical process FMEA.
  • To introduce a specialized 1-to-10-scale FMEA rating table for occurrence, severity, and detectability tailored to biopharmaceutical processes.
  • To enable effective risk identification and management throughout the biopharmaceutical product lifecycle.

Main Methods:

  • Development of a detailed guideline for biopharmaceutical process FMEA.
  • Creation of a 1-to-10-scale rating table for failure occurrence, severity, and detectability specific to biopharmaceutical manufacturing.
  • Application of FMEA for risk assessment during process development, scale-up, technology transfer, and optimization.

Main Results:

  • The proposed FMEA methodology and rating table facilitate the adaptation of risk management to biopharmaceutical processes.
  • Biopharmaceutical process FMEA allows for the ranking of process parameters by importance based on risk ratings.
  • Identification of critical process variables for development, characterization, and validation is improved.

Conclusions:

  • Implementing a biopharmaceutical process FMEA is crucial for managing risks in drug development and manufacturing.
  • The specialized FMEA guideline and rating table aid in identifying high-risk areas and improving medicine safety.
  • This approach supports regulatory compliance and enhances the overall quality of biopharmaceutical products.